MedRhythms

MedRhythms, Inc. is a digital therapeutics company that specializes in neurorehabilitation. Founded in 2015 and based in Portland, Maine, the company focuses on enhancing mobility and functional outcomes for individuals with neurological conditions. MedRhythms utilizes a proprietary platform that combines sensors, software, and music to engage neural circuitry. The company offers Neurologic Music Therapy (NMT) through its therapy division, which supports motor, speech, and cognitive rehabilitation. Their digital therapeutics pipeline includes sensor-based systems and software designed for conditions such as stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms emphasizes an evidence-based approach, integrating neuroscience and music therapy to optimize recovery and improve quality of life for chronic stroke survivors and others with neurological impairments. The company has been recognized for its innovative contributions to neurorehabilitation, including being named a Fast Company "Next Big Things in Tech" honoree in 2022.